COVID-19: A Review on Epidemiology, Clinical Features and Possible Potential Drugs Based on Available Case Studies
Authors:
- 1 March 2021
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Coronaviruses
- Vol. 2 (3) , 299-312
Abstract
: The emerging novel coronavirus disease 2019 has caused a global outbreak and significant public health concern. The World Health Organization (WHO) has announced a coronavirus disease outbreak a pandemic with a global public health emergency of international concern. As of now, 12th April 2020 almost 18,37,404 cases have been confirmed globally (in 209 countries) with almost 1,13,274 fatalities. This increasing number has created anxiety throughout the world, which has severely affected the whole world's culture, societies, behavioral patterns, peace and economics. At present, research on novel coronavirus is in the preliminary stage. There is no vaccine or specific antiviral to treat coronavirus disease. Also, very few case studies are available; hence it has become difficult to treat and to control this pandemic situation. In view of this, the present systematic review is done to highlight clinical epidemiology features, radiographic characteristics, and potential drugs based on available clinical case reports. Biomarkers for early diagnosis and impact of age, sex, pre-existing comorbidity on COVID-19 is also discussed. Further, this paper also outlines various possible antiviral chemical drug agents that can be potential and promising to treat this coronavirus disease in 2019. This review may be helpful for the medical practitioner, public health workers and government authorities to manage and deal with novel coronavirus disease 2019.Keywords
This publication has 71 references indexed in Scilit:
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathologySeminars in Immunopathology, 2017
- Coronaviruses — drug discovery and therapeutic optionsNature Reviews Drug Discovery, 2016
- Differences in the seasonality of Middle East respiratory syndrome coronavirus and influenza in the Middle EastInternational Journal of Infectious Diseases, 2015
- 25Cytokine, 2014
- Duration of Antibody Responses after Severe Acute Respiratory SyndromeEmerging Infectious Diseases, 2007
- SARS: Systematic Review of Treatment EffectsPLOS Medicine, 2006
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- SARS Transmission among Hospital Workers in Hong KongEmerging Infectious Diseases, 2004
- Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patientsJournal of Antimicrobial Chemotherapy, 2003
- Oseltamivir: a clinical and pharmacological perspectiveExpert Opinion on Pharmacotherapy, 2001